InflaRx N.V. (IFRX) Analysts See $-0.44 EPS

Analysts expect InflaRx N.V. (NASDAQ:IFRX) to report $-0.44 EPS on April, 4.After having $-0.31 EPS previously, InflaRx N.V.’s analysts see 41.94 % EPS growth. The stock increased 0.42% or $0.2 during the last trading session, reaching $47.28. About 9,258 shares traded. InflaRx N.V. (NASDAQ:IFRX) has risen 39.39% since March 20, 2018 and is uptrending. It has outperformed by 35.02% the S&P500.

InflaRx N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing inhibitors using C5a technology primarily in the United States and Europe. The company has market cap of $1.21 billion. The Company’s C5a is an inflammatory mediator involved in the enhancement of a variety of autoimmune and other inflammatory diseases. It currently has negative earnings. The company’s lead product candidate is IFX-1, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that is in the Phase IIb clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; to treat ANCA-associated vasculitis, a rare and life-threatening autoimmune disease; and for the treatment of other chronic/autoimmune diseases.

More notable recent InflaRx N.V. (NASDAQ:IFRX) news were published by: which released: “Technology Sector Update for 03/20/2019: SMAR, TME, MSFT, AAPL, IBM, CSCO, GOOG – Nasdaq” on March 20, 2019, also with their article: “Mandalay Resources Corporation Announces Fourth Quarter and Full-Year 2018 Financial Results – Nasdaq” published on March 14, 2019, published: “Biophytis Reports Annual 2018 Financial Results and Provides Operational Update – Nasdaq” on March 12, 2019. More interesting news about InflaRx N.V. (NASDAQ:IFRX) were released by: and their article: “InPlay Oil Corp. Announces its 2018 Financial, Operating and Reserves Results Highlighted by a 22% Increase in Light Oil and Liquids Growth over 2017 – Nasdaq” published on March 20, 2019 as well as‘s news article titled: “Village Farms’ Cannabis Operation Achieves Profitability; Stock Pops 7% – Nasdaq” with publication date: March 14, 2019.

InflaRx N.V. (NASDAQ:IFRX) Ratings Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *